Insider · CIK 0002132312
Ajay Aggarwal
Files at CRDF (Cardiff Oncology, Inc.). First filing -, latest -.
In brief
Ajay Aggarwal files SEC Form 4 as COO at CRDF (Cardiff Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ajay Aggarwal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | CRDF Cardiff Oncology, Inc. | AGrant or award Stock Optionsderivative | +400,000 | $0.00 | $0 | 400,000 | Apr 28, 2026 |
Questions about Ajay Aggarwal
Answered from the filings on this page, as of the latest one.
Is Ajay Aggarwal buying or selling?
Ajay Aggarwal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ajay Aggarwal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ajay Aggarwal has 0.
Where does Ajay Aggarwal file Form 4?
Ajay Aggarwal has filed Form 4 at CRDF (Cardiff Oncology, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.